[Changes in myocardial pH and their significance for the treatment of myocardial infarction and multi-stage cancer therapy].
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D003331:Coronary Vessels / Q000601:surgery; D003911:Dextrans / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D006352:Heart Ventricles / Q000503:physiopathology; D006863:Hydrogen-Ion Concentration; D008026:Ligation; D008832:Microchemistry / Q000295:instrumentation; D009203:Myocardial Infarction / Q000188:drug therapy*; D009206:Myocardium / Q000378:metabolism*; D009369:Neoplasms / Q000188:drug therapy*; D010042:Ouabain / Q000494:pharmacology; D051381:Rats; D012965:Sodium Chloride / Q000494:pharmacology
D003911:Dextrans; D012965:Sodium Chloride; D010042:Ouabain; D005947:Glucose
Zum pH-Verhalten des Myokards und seiner Bedeutung für Herzinfarkt- und Krebs-Mehrschritt-Therapie.